News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,249 Results
Type
Article (14137)
Company Profile (108)
Press Release (257002)
Multimedia
Podcasts (62)
Webinars (13)
Section
Business (88225)
Career Advice (466)
Deals (15377)
Drug Delivery (70)
Drug Development (36684)
Employer Resources (50)
FDA (6353)
Job Trends (6226)
News (150594)
Policy (14120)
Tag
Academia (441)
Accelerated approval (6)
Adcomms (7)
Allergies (56)
Alliances (23318)
ALS (49)
Alzheimer's disease (453)
Antibody-drug conjugate (ADC) (80)
Approvals (6464)
Artificial intelligence (168)
Autoimmune disease (24)
Automation (8)
Bankruptcy (150)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (92)
Biotechnology (40)
Bladder cancer (33)
Brain cancer (25)
Breast cancer (132)
Cancer (1078)
Cardiovascular disease (124)
Career advice (416)
Career pathing (13)
CAR-T (36)
CDC (6)
Cell therapy (125)
Cervical cancer (8)
Clinical research (31640)
Collaboration (568)
Compensation (269)
Complete response letters (30)
COVID-19 (776)
CRISPR (36)
C-suite (315)
Cystic fibrosis (52)
Data (1375)
Denatured (18)
Depression (28)
Diabetes (115)
Diagnostics (1359)
Digital health (6)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (92)
Drug pricing (102)
Drug shortages (12)
Duchenne muscular dystrophy (71)
Earnings (33098)
Editorial (16)
Employer branding (4)
Employer resources (45)
Events (38483)
Executive appointments (513)
FDA (7254)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (347)
Gene editing (58)
Generative AI (13)
Gene therapy (145)
GLP-1 (415)
Government (1383)
Grass and pollen (4)
Guidances (158)
Healthcare (3576)
HIV (7)
Huntington's disease (6)
IgA nephropathy (28)
Immunology and inflammation (59)
Immuno-oncology (5)
Indications (32)
Infectious disease (829)
Inflammatory bowel disease (68)
Inflation Reduction Act (7)
Influenza (19)
Intellectual property (91)
Interviews (60)
IPO (5910)
IRA (33)
Job creations (2055)
Job search strategy (374)
Kidney cancer (9)
Labor market (26)
Layoffs (204)
Leadership (8)
Legal (3448)
Liver cancer (21)
Longevity (6)
Lung cancer (159)
Lymphoma (90)
Machine learning (9)
Management (17)
Manufacturing (319)
MASH (59)
Medical device (1295)
Medtech (1298)
Mergers & acquisitions (9815)
Metabolic disorders (375)
Multiple sclerosis (39)
NASH (14)
Neurodegenerative disease (56)
Neuropsychiatric disorders (17)
Neuroscience (772)
NextGen: Class of 2025 (1588)
Non-profit (599)
Now hiring (16)
Obesity (195)
Opinion (137)
Ovarian cancer (33)
Pain (92)
Pancreatic cancer (39)
Parkinson's disease (64)
Partnered (9)
Patents (189)
Patient recruitment (87)
Peanut (12)
People (29497)
Pharmaceutical (64)
Pharmacy benefit managers (15)
Phase I (8216)
Phase II (13358)
Phase III (12054)
Pipeline (1085)
Policy (121)
Postmarket research (1401)
Preclinical (3304)
Press Release (25)
Prostate cancer (75)
Psychedelics (14)
Radiopharmaceuticals (125)
Rare diseases (272)
Real estate (2651)
Recruiting (18)
Regulatory (10640)
Reports (15)
Research institute (570)
Resumes & cover letters (55)
Rett syndrome (3)
RNA editing (5)
RSV (16)
Schizophrenia (58)
Series A (63)
Series B (34)
Service/supplier (3)
Sickle cell disease (40)
Special edition (10)
Spinal muscular atrophy (77)
Sponsored (8)
Startups (1640)
State (2)
Stomach cancer (3)
Supply chain (42)
Tariffs (66)
The Weekly (42)
Vaccines (215)
Venture capital (25)
Weight loss (126)
Women's health (13)
Worklife (4)
Date
Today (21)
Last 7 days (233)
Last 30 days (858)
Last 365 days (10816)
2025 (9072)
2024 (12502)
2023 (14250)
2022 (19558)
2021 (20070)
2020 (19034)
2019 (14893)
2018 (11717)
2017 (13888)
2016 (13129)
2015 (15474)
2014 (12423)
2013 (10593)
2012 (11401)
2011 (11923)
2010 (10888)
Location
Africa (318)
Alabama (17)
Alaska (1)
Arizona (69)
Arkansas (3)
Asia (20625)
Australia (2657)
California (2655)
Canada (1298)
China (437)
Colorado (113)
Connecticut (111)
Delaware (103)
Europe (40431)
Florida (517)
Georgia (55)
Hawaii (1)
Idaho (9)
Illinois (289)
India (33)
Indiana (208)
Iowa (1)
Japan (188)
Kansas (73)
Kentucky (18)
Louisiana (3)
Maine (2)
Maryland (377)
Massachusetts (2256)
Michigan (41)
Minnesota (142)
Mississippi (1)
Missouri (29)
Montana (8)
Nebraska (6)
Nevada (16)
New Hampshire (6)
New Jersey (1196)
New Mexico (7)
New York (768)
North Carolina (528)
North Dakota (2)
Northern California (1156)
Ohio (68)
Oklahoma (5)
Oregon (17)
Pennsylvania (634)
Puerto Rico (10)
Rhode Island (15)
South America (505)
South Carolina (8)
Southern California (1147)
Tennessee (47)
Texas (381)
United States (10876)
Utah (52)
Virginia (135)
Washington D.C. (41)
Washington State (183)
West Virginia (1)
Wisconsin (29)
Wyoming (1)
271,249 Results for "braeburn pharmaceutical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Braeburn Announces Publication of a Post Hoc Analysis of Data from Patients Using Fentanyl Treated with BRIXADI in a Phase 3 Efficacy and Safety Study
Braeburn Inc. announces the publication of a post hoc analysis in the Journal of the American Medical Association (JAMA) Network Open.
June 25, 2024
·
12 min read
FDA
Braeburn’s Long-Acting Brixadi Receives FDA Clearance to Treat Opioid Use Disorder
The FDA approved Braeburn Pharmaceuticals’ new buprenorphine treatment option with extended-release medication that could pave the way for greater patient compliance.
May 25, 2023
·
3 min read
·
Lisa Munger
Pharm Country
Braeburn’s BRIXADI™ (buprenorphine) Extended-Release Subcutaneous Injection (CIII) Receives FDA Approval for Moderate to Severe Opioid Use Disorder
Braeburn announces that the U.S. Food and Drug Administration (FDA) has approved BRIXADI (buprenorphine) extended-release injection for subcutaneous use (CIII), a new weekly and monthly medication for moderate to severe opioid use disorder (OUD).
May 23, 2023
·
12 min read
Sponsored
Best Pharmaceutical Label Manufacturers: Reviews and Comparisons
Selecting the ideal pharmaceutical label manufacturer requires careful consideration. This article compares leading companies, highlighting their strengths in regulatory compliance, material performance, serialization, innovation, and sustainability, to help you make an informed decision for your product’s safety and success.
October 27, 2025
·
6 min read
Press Releases
Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results
October 31, 2025
·
22 min read
Press Releases
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update
Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer’s disease pathology Further develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration Cash of $11.1M to support pharmaceutical developments into the fourth quarter of calendar year 2026
September 23, 2025
·
12 min read
Press Releases
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
October 31, 2025
·
1 min read
Press Releases
Corvus Pharmaceuticals Appoints David Moore to Board of Directors
October 3, 2025
·
5 min read
Press Releases
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements
October 14, 2025
·
7 min read
Press Releases
Corbus Pharmaceuticals Announces Proposed Public Offering
October 31, 2025
·
4 min read
1 of 27,125
Next
